COMPANY REGISTRATION NUMBER:
05592167
|
Integrated Medical Services Limited |
|
|
Filleted Unaudited Financial Statements |
|
|
Integrated Medical Services Limited |
|
|
Statement of Financial Position |
|
31 March 2026
|
31 Mar 26 |
30 Jun 25 |
|
Note |
£ |
£ |
£ |
£ |
|
|
|
|
|
Fixed assets
|
Investments |
5 |
|
1,005,856 |
|
1,005,856 |
|
|
|
|
|
|
Current assets
|
Cash at bank and in hand |
5,426 |
|
5,426 |
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
6 |
1,011,278 |
|
1,011,278 |
|
|
------------- |
|
------------- |
|
|
Net current liabilities |
|
1,005,852 |
|
1,005,852 |
|
|
------------- |
|
------------- |
|
Total assets less current liabilities |
|
4 |
|
4 |
|
|
---- |
|
---- |
|
Net assets |
|
4 |
|
4 |
|
|
---- |
|
---- |
|
|
|
|
|
|
Capital and reserves
|
Called up share capital |
|
4 |
|
4 |
|
|
---- |
|
---- |
|
Shareholders funds |
|
4 |
|
4 |
|
|
---- |
|
---- |
|
|
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
|
Integrated Medical Services Limited |
|
|
Statement of Financial Position (continued) |
|
31 March 2026
These financial statements were approved by the
board of directors
and authorised for issue on
4 November 2026
, and are signed on behalf of the board by:
Company registration number:
05592167
|
Integrated Medical Services Limited |
|
|
Notes to the Financial Statements |
|
Period from 1 July 2025 to 31 March 2026
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 4 Centurion Way, Brough, East Yorkshire, HU15 1AY.
2.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3.
Accounting policies
(a)
Basis of preparation
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
(b)
Consolidation
The entity has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the entity and its subsidiary undertakings comprise a small group.
(c)
Current & deferred tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
(d)
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
(e)
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
(f)
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residule interest in the assets of the company after deducting all of its liabilities.
4.
Employee numbers
The average number of persons employed by the company during the period, including the directors, amounted to 3 (2025: 3).
5.
Investments
|
Shares in group undertakings |
|
£ |
|
Cost |
|
|
At 1 July 2025 and 31 March 2026 |
1,005,856 |
|
------------- |
|
Impairment |
|
|
At 1 July 2025 and 31 March 2026 |
– |
|
------------- |
|
|
|
Carrying amount |
|
|
At 31 March 2026 |
1,005,856 |
|
------------- |
|
At 30 June 2025 |
1,005,856 |
|
------------- |
|
|
6.
Creditors:
amounts falling due within one year
|
31 Mar 26 |
30 Jun 25 |
|
£ |
£ |
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
279,697 |
280,849 |
|
Other loans |
729,213 |
729,213 |
|
Other creditors |
2,368 |
1,216 |
|
------------- |
------------- |
|
1,011,278 |
1,011,278 |
|
------------- |
------------- |
|
|
|